Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J1932 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11Office |
| Hospital Outpatient Group (APC) | APC 9051 - Inj, lanreotide, (cipla) 1mg |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 06360250 |
| Medicare Fee Schedule | $20.33 per 1 mg (October 2026 ASP)View Medicare rates for J1932 |
| Medicaid Fee Schedule | $30.685 median of the 8 states in the free previewView Medicaid rates for J1932 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 69097087067 - Lanreotide Acetate 120 mg/.5mL, injection |
National average reimbursement for HCPCS J1932 by major payers:

$40.69
BCBS / Anthem

$39.75
UnitedHealthcare

$45.20
Aetna

$39.87
Cigna
Choose a payer to see a sample of rates for HCPCS J1932.
University Of California Irvine, Uci Medical Center
Regents Of The University Of California At Irvine
Eisenhower Medical Center, Eisenhower Health
Eisenhower Medical Center
Wilbarger County Hospital District, Wilbarger General Hospital
Wilbarger General Hospital Employee Benefit Plan
Cayuga Medical Center
Cayuga Medical Center At Ithaca
Valley Hospitalists Group PLLC
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J1932 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J1932. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 69097087067-NDC | Lanreotide Acetate 120 mg/.5mL, injection |
| J1931-HCPCS | Injection, laronidase, 0.1 mg |
| J1932-HCPCS | Injection, lanreotide, (cipla), 1 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J1932. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J1932 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J1932) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J1932 to APC 9051 (Inj, lanreotide, (cipla) 1mg). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J1932 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J1932 under these revenue codes: 0636 and 0250. A revenue code names the hospital department or charge category for the line; it does not change what the service is.